Literature DB >> 25234251

Psychosocial and Neurohormonal Predictors of HIV Disease Progression (CD4 Cells and Viral Load): A 4 Year Prospective Study.

G Ironson1, C O'Cleirigh, M Kumar, L Kaplan, E Balbin, C B Kelsch, M A Fletcher, N Schneiderman.   

Abstract

Most studies of psychosocial predictors of disease progression in HIV have not considered norepinephrine (NE), a neurohormone related to emotion and stress, even though NE has been related to accelerated viral replication in vitro and impaired response to antiretroviral therapy (ART). We therefore examined NE, cortisol, depression, hopelessness, coping, and life event stress as predictors of HIV progression in a diverse sample. Participants (n = 177) completed psychological assessment, blood draws [CD4, viral load (VL)], and a 15 h urine sample (NE, cortisol) every 6 months over 4 years. Hierarchical linear modeling (HLM) was used to model slope in CD4 and VL controlling for ART at every time point, gender, age, race, SES, and initial disease status. NE (as well as depression, hopelessness, and avoidant coping) significantly predicted a greater rate of decrease in CD4 and increase in VL. Cortisol was not significantly related to CD4, but predicted VL increase. To our knowledge, this is the first study relating NE, in vivo, to accelerated disease progression over an extended time. It also extends our previous 2 year study by relating depressed mood and coping to accelerated disease progression over 4 years.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25234251      PMCID: PMC4465405          DOI: 10.1007/s10461-014-0877-x

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  56 in total

Review 1.  Psychosocial influences on HIV-1 disease progression: neural, endocrine, and virologic mechanisms.

Authors:  Steve W Cole
Journal:  Psychosom Med       Date:  2008-06       Impact factor: 4.312

2.  Depressive symptoms increase risk of HIV disease progression and mortality among women in Tanzania.

Authors:  Gretchen Antelman; Sylvia Kaaya; Ruilan Wei; Jessie Mbwambo; Gernard I Msamanga; Wafaie W Fawzi; Mary C Smith Fawzi
Journal:  J Acquir Immune Defic Syndr       Date:  2007-04-01       Impact factor: 3.731

3.  Fluoxetine treatment for depression in patients with HIV and AIDS: a randomized, placebo-controlled trial.

Authors:  J G Rabkin; G J Wagner; R Rabkin
Journal:  Am J Psychiatry       Date:  1999-01       Impact factor: 18.112

4.  Hydrocortisone and some other hormones enhance the expression of HTLV-III.

Authors:  P D Markham; S Z Salahuddin; K Veren; S Orndorff; R C Gallo
Journal:  Int J Cancer       Date:  1986-01-15       Impact factor: 7.396

5.  Impaired response to HAART in HIV-infected individuals with high autonomic nervous system activity.

Authors:  S W Cole; B D Naliboff; M E Kemeny; M P Griswold; J L Fahey; J A Zack
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-23       Impact factor: 11.205

6.  Norepinephrine enhances adhesion of HIV-1-infected leukocytes to cardiac microvascular endothelial cells.

Authors:  J B Sundstrom; D E Martinson; M Mosunjac; P Bostik; L K McMullan; R M Donahoe; M B Gravanis; A A Ansari
Journal:  Exp Biol Med (Maywood)       Date:  2003-06

Review 7.  HIV disease progression: depression, stress, and possible mechanisms.

Authors:  Jane Leserman
Journal:  Biol Psychiatry       Date:  2003-08-01       Impact factor: 13.382

Review 8.  HIV and depression: 2008 review and update.

Authors:  Judith G Rabkin
Journal:  Curr HIV/AIDS Rep       Date:  2008-11       Impact factor: 5.071

9.  Norepinephrine accelerates HIV replication via protein kinase A-dependent effects on cytokine production.

Authors:  S W Cole; Y D Korin; J L Fahey; J A Zack
Journal:  J Immunol       Date:  1998-07-15       Impact factor: 5.422

10.  Depressive symptoms and CD4 lymphocyte decline among HIV-infected men.

Authors:  J H Burack; D C Barrett; R D Stall; M A Chesney; M L Ekstrand; T J Coates
Journal:  JAMA       Date:  1993-12-01       Impact factor: 56.272

View more
  37 in total

1.  The role of catecholamines in HIV neuropathogenesis.

Authors:  R Nolan; P J Gaskill
Journal:  Brain Res       Date:  2018-04-27       Impact factor: 3.252

2.  Engagement in Care, Psychological Distress, and Resilience are Associated with Sleep Quality among HIV-Positive Gay, Bisexual, and Other Men Who Have Sex with Men.

Authors:  Martin J Downing; Steven T Houang; Roberta Scheinmann; Irene S Yoon; Mary Ann Chiasson; Sabina Hirshfield
Journal:  Sleep Health       Date:  2016-09-19

3.  The benefits of yoga for people living with HIV/AIDS: A systematic review and meta-analysis.

Authors:  Eugene M Dunne; Brittany L Balletto; Marissa L Donahue; Melissa M Feulner; Julie DeCosta; Dean G Cruess; Elena Salmoirago-Blotcher; Rena R Wing; Michael P Carey; Lori A J Scott-Sheldon
Journal:  Complement Ther Clin Pract       Date:  2018-11-08       Impact factor: 2.446

4.  Psychological Distress Mediates the Effect of Alexithymia on 2-Year Change in HIV Viral Load.

Authors:  Roger C McIntosh; Gail Ironson; Michael Antoni; Betty Lai; Mahendra Kumar; Mary Ann Fletcher; Neil Schneiderman
Journal:  Int J Behav Med       Date:  2017-04

5.  Hospitalization for Anxiety and Mood Disorders in HIV-Infected and -Uninfected Gay and Bisexual Men.

Authors:  Cecilia L Moore; Andrew E Grulich; Garrett Prestage; Heather F Gidding; Fengyi Jin; Kathy Petoumenos; Iryna B Zablotska; I Mary Poynten; Limin Mao; Matthew G Law; Janaki Amin
Journal:  J Acquir Immune Defic Syndr       Date:  2016-12-15       Impact factor: 3.731

6.  The Selective Serotonin Reuptake Inhibitor Citalopram Decreases Human Immunodeficiency Virus Receptor and Coreceptor Expression in Immune Cells.

Authors:  Jeffrey M Greeson; David R Gettes; Sergei Spitsin; Benoit Dubé; Tami D Benton; Kevin G Lynch; Steven D Douglas; Dwight L Evans
Journal:  Biol Psychiatry       Date:  2015-11-10       Impact factor: 13.382

7.  Depression and Survival in a 17-Year Longitudinal Study of People With HIV: Moderating Effects of Race and Education.

Authors:  Gail Ironson; Calvin Fitch; Rick Stuetzle
Journal:  Psychosom Med       Date:  2017-09       Impact factor: 4.312

Review 8.  Psychosocial risk and management of physical diseases.

Authors:  Neil Schneiderman; Roger C McIntosh; Michael H Antoni
Journal:  J Behav Med       Date:  2019-01-10

9.  Considering high alcohol and violence neighborhood context using daily diaries and GPS: A pilot study among people living with HIV.

Authors:  Katherine P Theall; Erica Felker-Kantor; Maeve Wallace; Xiao Zhang; Christopher N Morrison; Douglas J Wiebe
Journal:  Drug Alcohol Depend       Date:  2018-04-10       Impact factor: 4.492

10.  Recent stimulant use and leukocyte gene expression in methamphetamine users with treated HIV infection.

Authors:  Adam W Carrico; Annesa Flentje; Kord Kober; Sulggi Lee; Peter Hunt; Elise D Riley; Steven Shoptaw; Elena Flowers; Samantha E Dilworth; Savita Pahwa; Bradley E Aouizerat
Journal:  Brain Behav Immun       Date:  2018-04-18       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.